Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof
Abstract:
The invention provides compositions and methods for treating a disease or disorder associate with vascular endothelial growth factor (VEGF). Specifically, the invention relates to an oligomerized VEGF binding domain to provide VEGF antagonism, and thereby treat diseases associated thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0